We used the Health Belief Model (HBM) to explore factors associated with readiness for genetic counseling among breast cancer survivors. Breast cancer survivors meeting NCCN genetic counseling referral criteria completed questionnaires capturing demographic and clinical information and factors guided by the HBM, including health beliefs, psychosocial variables, and cues to action. Using logistic regression, we examined whether the above variables differed based on readiness group (precontemplators, who did not plan to make a genetic counseling appointment, and contemplators, who planned to make a genetic counseling appointment in the next 1-6 months). Of 111 participants, 57% were pre-contemplators and 43% were contemplators. Higher cancer worry was associated with increased odds of being a contemplator (OR = 2.99; 95% CI = 1.37-6.54) and higher perceived barriers to genetic counseling were associated with decreased odds of being a contemplator (OR = 0.31; 95% CI = 0.11-0.85). Those who reported a family member encouraged them to get tested were more likely to be contemplators (OR = 3.57; 95% CI = 1.19-10.70). Our results suggest key factors for predicting genetic counseling readiness include cancer worry, perceived barriers, and family influence. There is need for increased genetic counseling awareness. Better understanding of factors related to survivors' decisions about counseling can inform tailored interventions to improve uptake and ultimately reduce cancer recurrence risk.
| INTRODUCTION
Female breast cancer (BC) survivors with a BRCA mutation have an increased risk of future cancer compared to patients without a BRCA mutation. 1 Diagnosis is the optimal time to identify, counsel, and test BC patients at increased risk for hereditary cancer; however, genetic counseling (GC) is underutilized. 2, 3 The survivorship care setting represents an important opportunity to provide GC for women at risk for hereditary cancer, and ultimately reduce the risk of second primary cancers in BC patients. 4 Genetic counseling provides education and counseling about hereditary cancer and the process, risk and benefits of genetic testing. 5 BC patients who attend GC have increased knowledge about cancer genetics, improved risk perception accuracy, and reduced
| Health beliefs
Perceived Risk was assessed using a single item, "On a scale from 0 to 100, where 0 is no chance at all and 100 is absolutely certain, what do you think are the chances that you will get breast cancer sometime during your lifetime?" 16 Perceived Susceptibility and Perceived Severity were measured with 5 and 2 items, respectively by adapting subscales of Champion's HBM Scale. 17 
Perceived Benefits
and Perceived Barriers to GC were assessed using subscales of a 20-item scale developed for the current study. All items were rated on a 5-point Likert-type scale where lower scores indicate less perceived benefit (six items)/barrier (13 items). Perceived Self-Efficacy was assessed using an adapted version of the 5-item Champion Self
Efficacy scale. 18 All items are rated on a 5-point Likert-type scale where lower scores indicate lower levels of a particular belief.
| Cues to action
Provider Encouragement of GC Participants were asked their perception about whether their doctor wanted them to have GC on a 5-point scale where lower scores indicated a belief the doctor did not want them to be tested. Cancer Family History was assessed by reports of cancer diagnoses of one or both biological parents. Family Encouragement of GC Participants were asked to indicate the degree to which family members want/ed them to have GC. Due to a non-normal distribution, we dichotomized this variable; if participants indicated "strongly agree" or "agree" this variable was coded as "yes."
| Psychosocial variables
Cancer Worry was assessed by the 3-item Lerman Cancer Worry Scale. 19 Items are rated on a 4-point Likert-type scale in which lower scores indicate lower levels of worry (potential range = 4-12). Intrusiveness (seven items) and Avoidance (eight items) were assessed as subscales of the 15-item Impact of Events Scale (IES). 20 Items were rated on a 4-point Likert-type scale where lower overall scores indicate lower subjective distress.
| Open ended responses
Participants were asked to respond to the following: "Please briefly explain why you have not attended GC."
| Analysis
Data were summarized with descriptive statistics. We examined whether the demographic, clinical, and HBM variables differed based on readiness group (pre-contemplators and contemplators) using simple logistic regression. We subsequently entered all variables into a multiple logistic regression model; variables with a significance level of 0.1 remained in the model.
| RESULTS
Of the 233 women screened, 146 met eligibility criteria, and 119 (81%) enrolled and completed a baseline questionnaire. One participant was excluded due to a scheduled GC appointment at baseline. 
| Comparison between pre-contemplator and contemplator survivors
In univariable analyses (Table 2) , the odds of being a contemplator decreased with increasing age (OR = 0.96; 95% CI = 0.93-0.99).
There was no difference in other demographic variables or GC knowledge between groups, but knowledge was relatively low. We found no significant differences in perceived risk or susceptibility for Only three variables remained in the final multivariable model (Table 2) Perception of provider encouragement did not differ between groups, but there was low overall provider GC communication.
Responses to the open-ended question about why individuals hadn't participated in GC revealed many women simply didn't know about GC. Typical responses included:
I was not offered counseling nor did I know it was offered where I was receiving care.Doctors never mentioned it to me and I never thought of it myself.
The number of participants indicating family members wanted them to get testing was low (32.1%). However, those who did report a family member encouraged them to get tested were almost three 
| Conclusion
Genetic counseling provides an opportunity for BC survivors to learn more about their risks for new primary cancers and reduce anxiety and cancer-related distress. 6 We explored HBM factors that may impact BC survivors' readiness to engage in GC. This study is one of the few to investigate the differences between groups at different stages of contemplation prior to receiving GC. 10, 21 In our study, more women were in the pre-contemplation than the contemplation phase. Contemplators were younger, but no other demographic differences were found between groups. Knowledge about GC was also low, consistent with other research. 22 Health belief and affective factors played an important role in distinguishing pre-contemplators from contemplators. Our results suggest that both worry and a lack of barriers may be important for behavior change. For example, intention to engage in GC was related to lower perceived barriers to counseling and higher levels of concern about cancer in two ethnically-diverse samples. 23, 24 In both studies, as well as other research on GC uptake in BC survivors, 12 participants' perception of their family's wishes and family dynamics also played an important role in their decision.
While family member encouragement of testing significantly pre- 
